Bill
S 848
Requires annual reporting by covered entities in Massachusetts on 340B program activity and costs, with public posting by CHIA.
Note on documents and metadata
- The materials provided contain two different bills that share the S.848 designation in different jurisdictions: (A) a federal bill introduced in the U.S. Senate — the “REPORT Act” — and (B) a Massachusetts state bill (Senate Docket No. 2318 / S.848) requiring annual reporting by covered entities about 340B drug program activity. Metadata in the packet (titles, legislative actions, and “SIGNED CHAP.254”) appears to mix both tracks. Below are clear, separate summaries of each measure and their procedural status as shown in the documents.
Primary sponsors: Sen. Maggie Hassan (with Sen. Mike Lee cosponsoring)
Purpose and intent
- Require coordinated, timely reports from relevant federal national-security/law‑enforcement agencies to Congress after incidents of terrorism to improve oversight, identify security gaps, and recommend preventive measures.
Key provisions
- Duty to Report: After an act of terrorism in the U.S., the Secretary of Homeland Security, the Attorney General, the FBI Director, and as appropriate the Director of the National Counterterrorism Center (NCTC) must:
- Submit to designated congressional committees an unclassified report (may include a classified annex) no later than 1 year after the investigating agency completes its investigation.
- Make the unclassified report publicly available on a website.
- Reports may be combined into a quarterly submission.
- Any unclassified report/classified annex must be available to any Member of Congress on request.
- Report content: known facts of the incident, identified homeland/national security gaps, and recommendations (including law enforcement practice changes or statutory changes) to help prevent future acts.
- Exception: Agencies may withhold information that would jeopardize ongoing investigations/prosecutions but must notify the appropriate congressional committees; withholding does not relieve obligation to report other non‑jeopardizing information.
- Sunset: The reporting requirement terminates 5 years after enactment.
- Savings: The Act does not grant NCTC investigatory or prosecutorial authority.
Who is affected
- Federal agencies named (DHS, DOJ/AG, FBI, NCTC) and Congress; broader public benefits from greater transparency and oversight of post‑terrorism lessons and recommendations.
Procedural / timeline
- Introduced in Senate 3/5/2025; referred to Senate Homeland Security & Governmental Affairs Committee; reported and placed on Senate calendar per the document. (No indication in the provided federal text that it became law.)
Sponsor: Senator John J. Cronin
Purpose and intent
- Increase transparency and accountability for “covered entities” participating in the federal 340B drug discount program, with emphasis on safeguarding benefits for vulnerable patients.
Key provisions
- New Section 9A (Chapter 12C): Beginning April 1, 2026, each covered entity must annually report to the state’s Center for Health Information and Analysis (CHIA) for the prior year, including:
- By payer type (Medicaid, Medicare, commercial, uninsured): aggregate acquisition cost for covered outpatient drugs; aggregated payments received; total prescriptions and share filled with 340B drugs.
- Total operating costs, with itemized costs for implementing point‑of‑dispensing 340B pass‑through discounts, sliding fee scales for patients <200% FPG, and charity care.
- Total payments to contract pharmacies, third‑party administrators, and other vendors for 340B‑related services/compliance.
- Number and location (in‑/out‑of‑state) of contract pharmacies; prescriptions filled at contract pharmacies; remuneration retained by contract pharmacies; year‑over‑year change in remuneration.
- Certification: an officer of the covered entity must certify accuracy.
- Public posting: CHIA must publish all submitted reports on a publicly accessible website.
- Effective upon passage.
Who is affected
- Covered entities as defined by the federal 340B statute (hospitals, certain clinics) and their contract pharmacies; state health oversight body (CHIA); patients and payers benefit from increased transparency.
Procedural / timeline / status
- Filed Jan 17, 2025; enacted by the Commonwealth and delivered to the Governor; document shows “SIGNED CHAP.254” on Aug 7, 2025 (indicating chaptered law in Massachusetts).
If you’d like, I can:
- Produce a side‑by‑side comparison of the two measures,
- Extract proposed report templates/fields for either bill, or
- Track current legislative status and subsequent agency guidance or implementation timelines.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
